Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) - Drugs in Development, 2021
- $ 3500
- May 2024
- 305 pages
Report covers products from therapy areas Immunology, Dermatology, Gastrointestinal, Oncology, Musculoskeletal Disorders, Respiratory, Infectious Disease, Central Nervous System, Cardiovascular, Genetic Disorders, Hematological Disorders, Hormonal Disorders, Metabolic Disorders, Ophthalmology and Women's Health which include indications Rheumatoid Arthritis, Atopic Dermatitis (Atopic Eczema), Alopecia Areata, Psoriasis, Systemic Lupus Erythematosus, Ulcerative Colitis, Crohn's Disease (Regional Enteritis), Coronavirus Disease 2019 (COVID-##), Myelofibrosis, Vitiligo, Graft Versus Host Disease (GVHD), Inflammation, Inflammatory Bowel Disease, Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), Ankylosing Spondylitis (Bekhterev's Disease), Asthma, Diffuse Large B-Cell Lymphoma, Hidradenitis Suppurativa, Multiple Sclerosis, Peripheral T-Cell Lymphomas (PTCL), Anaplastic Large Cell Lymphoma (ALCL), Autoimmune Disorders, B-Cell Non-Hodgkin Lymphoma, Bronchiolitis Obliterans, Chronic Lymphocytic Leukemia (CLL), Cytokine Release Syndrome (Cytokine Storm), Dermatitis (Eczema), Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease), Head And Neck Cancer Squamous Cell Carcinoma, Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Mantle Cell Lymphoma, Myelodysplastic Syndrome, Non-Small Cell Lung Cancer, Psoriatic Arthritis, Sicca Syndrome (Sjogren), Systemic- Onset Juvenile Idiopathic Arthritis (Still Disease), T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia), Triple-Negative Breast Cancer (TNBC), Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma), Acute Lung Injury, Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia), Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Aicardi-Goutieres Syndrome (AGS), Androgenic Alopecia, Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy, Arthritis, Auto Inflammatory Disease, B-Cell Chronic Lymphocytic Leukemia, Breast Hyperplasia, Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia), Chronic Myelomonocytic Leukemia (CMML), Colon Cancer, Colorectal Cancer, Cutaneous Lupus Erythematosus, Cutaneous T-Cell Lymphoma, Endometrial Cancer, Epstein-Barr Virus (HHV-##) Infections, Essential Thrombocythemia, Follicular Lymphoma, Gastric Cancer, Graves Diseases, Hairy Cell Leukemia, Hemophagocytic Lymphohistiocytosis, Hepatocellular Carcinoma, Hypereosinophilic Syndrome, Hypopharyngeal Cancer, Idiopathic Pulmonary Fibrosis, Juvenile Arthritis, Keratoconjunctivitis Sicca (Dry Eye), Kidney Cancer (Renal Cell Cancer), Laryngeal Cancer, Leiomyosarcoma, Lipodystrophy (Lipoatrophy), Lupus Erythematosus, Lupus Nephritis, Lymphoma, Marginal Zone B-cell Lymphoma, Melanoma, Myeloproliferative Disorders, Myxoid Liposarcoma, Natural Killer Cell Lymphomas, Non-Hodgkin Lymphoma, Oligoarticular Idiopathic Juvenile Arthritis, Oral Cavity (Mouth) Cancer, Oropharyngeal Cancer, Osteoarthritis, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Plaque Psoriasis (Psoriasis Vulgaris), Polyarticular Juvenile Idiopathic Arthritis (PJIA), Polycythemia Vera, Polymyalgia Rheumatica (PMR), Prurigo, Pulmonary Arterial Hypertension, Refractory Acute Myeloid Leukemia, Refractory Multiple Myeloma, Relapsed Acute Myeloid Leukemia, Relapsed Multiple Myeloma, Renal Cell Carcinoma, Skin Cancer, Solid Tumor, Spondyloarthritis (Spondyloarthropathy), Squamous Cell Carcinoma, Synovial Sarcoma, Systemic Idiopathic Juvenile Arthritis, T-Cell Lymphomas, Takayasu Arteritis, Thrombocythemia Myelofibrosis and Transitional Cell Carcinoma (Urothelial Cell Carcinoma).